GB Patent

GB0617581D0 — Biomarkers for assessing liver function

Assigned to UCL Business Ltd · Expires 2006-10-18 · 20y expired

What this patent protects

A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA): albumin ratio (IMAR) in the individual, thereby to assess liver function in the i…

USPTO Abstract

A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA): albumin ratio (IMAR) in the individual, thereby to assess liver function in the individual.

Drugs covered by this patent

Patent Metadata

Patent number
GB0617581D0
Jurisdiction
GB
Classification
—
Expires
2006-10-18
Drug substance claim
No
Drug product claim
No
Assignee
UCL Business Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.